AmoyDx Pan Lung Cancer PCR Panel
Multiplex real-time PCR panel for actionable DNA alterations and RNA fusions across 11 lung-cancer genes.
- Developer
- Amoy Diagnostics
- Intended use
- Other
- Cancer scope
- Non-small cell lung cancer
- Specimen
- FFPE tumor tissue
- Molecular modality
- DNA mutation, RNA expression
- Current version
- Current AmoyDx Pan Lung Cancer PCR Panel (2026-09)
- Evidence context
- 0 structured studies · 0 indexed performance results · 1 sources
Why can reported performance numbers differ? MDI keeps each result attached to its study, population, stage or stratum, test version and source rather than treating performance as a fixed property of the test.